Private equity firm Gryphon inks deal to infuse investment in Pacur
Category: #business  By Saipriya Iyer  Date: 2020-02-13
  • share
  • Twitter
  • Facebook
  • LinkedIn
Private equity firm Gryphon inks deal to infuse investment in Pacur

Gryphon, a private equity company based in San Francisco, has inked a fresh deal to infuse investment in Pacur, a major supplier of specialty plastic packaging materials meant for the medical device landscape.

Gryphon Deal Partner and Industrial Growth Group Head Bob Grady expressed his reverence to be partnering with the Johnson family and Pacur’s management team to expand leadership of the company in the materials and medical packaging industry. Discussing the deal, he went on to emphasize that Pacur’s reputation for reliability and quality, first-class brand, and resounding history of bullish financial performance and exceptional customer service were enough to contemplate investment in the company.

He claimed that medical device market is recession resistance and the investment was on the heels of multi-year initiatives to eye for investments in companies that have high-quality advanced materials. Grady was full praise for Pacur’s novel product pipeline, its penetration in the medical device value chain and team-induced culture.

In the similar vein, Barry Johnson, Pacur’s CEO, stated that there was no looking further given the legacy of Gryphon in developing business-focused initiatives, providing advanced industry deep dive and fostering deals with family-owned business.

Elaborating on the deal, Johnson stated how important the partnership was given the fact that they are vying to expand their sustainable and eco-friendly plastics products. He said that Pacur will continue to boost their high-touch business model on the parameters of integrity, responsiveness and dependability.

West Lucas, Head of Gryphon’s Operations Resources Group and Gryphon’s Industrial Growth Group Operating Partner, spoke in the same breadth of Bob Grady and stressed that Pacur has proved its mettle focusing on innovations and providing “best-in-class” packaging solutions.

According to reports, Johnson family will continue to remain major owners of the company and Barry Johnson, leading the Pacur’s management team will continue to manage the business.

Source credit:

https://www.prnewswire.com/news-releases/gryphon-signs-agreement-to-make-strategic-investment-in-pacur-301002442.html 

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Saipriya Iyer

Saipriya Iyer    

Saipriya Iyer currently works as a content developer for GroundAlerts. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had previous experience of 3 years under her belt, she has dabbled with website ...

Read More >>

More News By Saipriya Iyer

Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
Global Wooden Furniture Market by Key Players, Countries, Segments and Application, Forecast to 2027
By Saipriya Iyer

Global wooden furniture market is poised to witness a tremendous growth over the projected timeframe of 2020 to 2026 on account of rising number of residential and commercial construction activities across the globe. Alongside, increasing consumer in...

Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
Cladribine Market Growth Manufacturers, Regions, Product Types, Major Application Analysis & Forecast To 2026
By Saipriya Iyer

Global Cladribine Market Research Report: Size, Share, Trends, Industry Growth, Opportunity, Application, Production, Segmentation, Cost Structure, Company Profile, Product Picture and Specifications during the Forecast period by 2026 Executive summ...

Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
Cardiovascular Disease Drugs Market size and Key Trends in terms of volume and value 2021-2026
By Saipriya Iyer

Global Cardiovascular Disease Drugs ?Market report 2026 focuses on the major Types and Applications for the key players. Global Cardiovascular Disease Drugs market research report also provides analysis of the market share, segmentation, revenue fore...